DE60133897D1 - Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren - Google Patents
Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitorenInfo
- Publication number
- DE60133897D1 DE60133897D1 DE60133897T DE60133897T DE60133897D1 DE 60133897 D1 DE60133897 D1 DE 60133897D1 DE 60133897 T DE60133897 T DE 60133897T DE 60133897 T DE60133897 T DE 60133897T DE 60133897 D1 DE60133897 D1 DE 60133897D1
- Authority
- DE
- Germany
- Prior art keywords
- chinazolin
- aurora
- derivatives
- substituted
- kinase inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical class N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00401842 | 2000-06-28 | ||
PCT/SE2001/001450 WO2002000649A1 (en) | 2000-06-28 | 2001-06-21 | Substituted quinazoline derivatives and their use as inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60133897D1 true DE60133897D1 (de) | 2008-06-19 |
Family
ID=8173742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60133897T Expired - Fee Related DE60133897D1 (de) | 2000-06-28 | 2001-06-21 | Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren |
Country Status (27)
Country | Link |
---|---|
US (2) | US6919338B2 (de) |
EP (1) | EP1299381B1 (de) |
JP (1) | JP2004501914A (de) |
KR (1) | KR20030014411A (de) |
CN (1) | CN1267431C (de) |
AR (1) | AR030432A1 (de) |
AT (1) | ATE394102T1 (de) |
AU (1) | AU2001266505A1 (de) |
BG (1) | BG107376A (de) |
BR (1) | BR0111754A (de) |
CA (1) | CA2412592A1 (de) |
CZ (1) | CZ20024120A3 (de) |
DE (1) | DE60133897D1 (de) |
EE (1) | EE200200715A (de) |
ES (1) | ES2305081T3 (de) |
HK (1) | HK1053124A1 (de) |
HU (1) | HUP0301236A2 (de) |
IL (1) | IL153246A0 (de) |
IS (1) | IS6656A (de) |
MX (1) | MXPA02011974A (de) |
NO (1) | NO20026010L (de) |
NZ (1) | NZ522696A (de) |
PL (1) | PL360439A1 (de) |
RU (1) | RU2283311C2 (de) |
SK (1) | SK18102002A3 (de) |
WO (1) | WO2002000649A1 (de) |
ZA (1) | ZA200209412B (de) |
Families Citing this family (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050026811A1 (en) * | 2003-05-20 | 2005-02-03 | Mjalli Adnan M. M. | Rage antagonists as agents to reverse amyloidosis and diseases associated therewith |
US6660731B2 (en) * | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
IL154817A0 (en) * | 2000-09-15 | 2003-10-31 | Vertex Pharma | Pyrazole derivatives and pharmaceutical compositions containing the same |
US7473691B2 (en) * | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
ES2272567T3 (es) * | 2000-12-21 | 2007-05-01 | Vertex Pharmaceuticals Incorporated | Compuestos de pirazol utiles como inhibidores de proteina quinasas. |
NZ533440A (en) * | 2001-12-24 | 2006-08-31 | Astrazeneca Ab | Substituted quinazoline derivatives as inhibitors of aurora kinases |
MXPA04007697A (es) * | 2002-02-06 | 2004-11-10 | Vertex Pharma | Compuestos de heteroarilo utiles como inhibidores de gsk-3. |
EP2324830A1 (de) * | 2002-03-05 | 2011-05-25 | TransTech Pharma Inc. | Verfahren zur Herstellung von einem monozylische Azolderivat das die Interaktion von Liganden mit Rage hemmt |
US20040009981A1 (en) * | 2002-03-15 | 2004-01-15 | David Bebbington | Compositions useful as inhibitors of protein kinases |
RU2004135386A (ru) * | 2002-05-06 | 2005-07-20 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Тиадиазолы или оксадиазолы и их применение в качестве ингибиторов протеинкиназы jak |
MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
US7576074B2 (en) | 2002-07-15 | 2009-08-18 | Rice Kenneth D | Receptor-type kinase modulators and methods of use |
WO2004013140A1 (en) | 2002-08-02 | 2004-02-12 | Vertex Pharmaceuticals Incorporated | Pyrazole compositions useful as inhibitors of gsk-3 |
GB0221245D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Chemical process |
DK1578755T3 (da) | 2002-12-24 | 2007-11-12 | Astrazeneca Ab | Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse |
AU2003290322A1 (en) | 2002-12-24 | 2004-07-22 | Astrazeneca Ab | Quinazoline compounds |
CN101074227B (zh) * | 2002-12-24 | 2010-09-29 | 阿斯利康(瑞典)有限公司 | 膦酰氧基喹唑啉衍生物及其药物用途 |
WO2004072029A2 (en) * | 2003-02-06 | 2004-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridazines useful as inhibitors of protein kinases |
CA2522079A1 (en) * | 2003-04-16 | 2004-11-04 | Astrazeneca Ab | Quinazoline derivatives for treatment of cancer |
JP2006526599A (ja) * | 2003-06-02 | 2006-11-24 | アストラゼネカ アクチボラグ | 癌のような増殖性疾患の治療のためのオーロラキナーゼインヒビターとしての(3−((キナゾリン−4−イル)アミノ)−1h−ピラゾール−1−イル)アセトアミド誘導体及び関連化合物 |
TW200505452A (en) * | 2003-06-17 | 2005-02-16 | Astrazeneca Ab | Chemical compounds |
GB0320793D0 (en) * | 2003-09-05 | 2003-10-08 | Astrazeneca Ab | Chemical process |
EP2392564B1 (de) | 2003-09-26 | 2013-10-23 | Exelixis, Inc. | c-Met-Modulatoren und Anwendungsverfahren |
US20080051414A1 (en) * | 2003-10-14 | 2008-02-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
US20090143399A1 (en) * | 2003-10-14 | 2009-06-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
US7326712B2 (en) * | 2003-10-14 | 2008-02-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Substituted tricyclic compounds as protein kinase inhibitors |
US20090099165A1 (en) * | 2003-10-14 | 2009-04-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
AU2004285052A1 (en) * | 2003-10-31 | 2005-05-12 | Neurogen Corporation | 4-amino (AZA) quinoline derivatives as capsaicin receptor agonists |
EP1694671A2 (de) * | 2003-12-04 | 2006-08-30 | Vertex Pharmaceuticals Incorporated | Als inhibitoren von proteinkinasen geeignete chinoxaline |
US7572914B2 (en) | 2003-12-19 | 2009-08-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
WO2005066152A1 (en) * | 2003-12-30 | 2005-07-21 | The Brigham And Women's Hospital, Inc. | Thiophene derivatives for up-regulating hla-dm activity |
CN1934100A (zh) * | 2004-03-23 | 2007-03-21 | 万有制药株式会社 | 取代喹唑啉或吡啶并嘧啶衍生物 |
WO2005105788A1 (en) * | 2004-04-23 | 2005-11-10 | Takeda San Diego, Inc. | Indole derivatives and use thereof as kinase inhibitors |
WO2006023931A2 (en) | 2004-08-18 | 2006-03-02 | Takeda San Diego, Inc. | Kinase inhibitors |
WO2006040520A1 (en) * | 2004-10-12 | 2006-04-20 | Astrazeneca Ab | Quinazoline derivatives |
WO2006040522A1 (en) * | 2004-10-12 | 2006-04-20 | Astrazeneca Ab | Quinoline derivatives |
US7713973B2 (en) | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
CN1854130B (zh) * | 2005-04-15 | 2011-04-20 | 中国医学科学院药物研究所 | 喹唑啉衍生物、及其制法和药物组合物与用途 |
GB0509227D0 (en) * | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Intracellular enzyme inhibitors |
GB0510963D0 (en) * | 2005-05-28 | 2005-07-06 | Astrazeneca Ab | Chemical compounds |
AU2006279376B2 (en) * | 2005-08-18 | 2011-04-14 | Vertex Pharmaceuticals Incoporated | Pyrazine kinase inhibitors |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
AR056763A1 (es) * | 2005-11-03 | 2007-10-24 | Vertex Pharma | Aminopirimidinas sustituidas con tiazol o pirazol,utiles como agentes anticancer y composiciones farmaceuticas que las contienen. |
EP1785420A1 (de) * | 2005-11-14 | 2007-05-16 | 4Sc Ag | Thiazolanalogen und ihre Verwendung |
US7560551B2 (en) * | 2006-01-23 | 2009-07-14 | Amgen Inc. | Aurora kinase modulators and method of use |
GEP20125643B (en) | 2006-01-23 | 2012-09-25 | Amgen Inc | Aurora kinase modulators and method of using same |
US7868177B2 (en) * | 2006-02-24 | 2011-01-11 | Amgen Inc. | Multi-cyclic compounds and method of use |
EP1994024A2 (de) * | 2006-03-02 | 2008-11-26 | AstraZeneca AB | Chinolinderivate |
UY30183A1 (es) | 2006-03-02 | 2007-10-31 | Astrazeneca Ab | Derivados de quinolina |
WO2007113005A2 (en) * | 2006-04-03 | 2007-10-11 | European Molecular Biology Laboratory (Embl) | 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors |
GEP20135728B (en) | 2006-10-09 | 2013-01-25 | Takeda Pharmaceuticals Co | Kinase inhibitors |
WO2008044045A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
JP5528806B2 (ja) | 2006-10-12 | 2014-06-25 | アステックス、セラピューティックス、リミテッド | 複合薬剤 |
WO2008057280A1 (en) | 2006-10-27 | 2008-05-15 | Amgen Inc. | Multi-cyclic compounds and methods of use |
WO2008055233A1 (en) * | 2006-10-31 | 2008-05-08 | Supergen, Inc. | Protein kinase inhibitors |
AU2007317435A1 (en) * | 2006-11-02 | 2008-05-15 | Vertex Pharmaceuticals Incorporated | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
MX2009006690A (es) * | 2006-12-19 | 2009-07-31 | Vertex Pharma | Aminopirimidinas utiles como inhibidores de proteinas cinasas. |
CA2679701A1 (en) * | 2007-03-09 | 2008-09-18 | Vertex Pharmaceuticals Incorporated | Aminopyridines useful as inhibitors of protein kinases |
CN101663295B (zh) * | 2007-03-09 | 2014-11-05 | 沃泰克斯药物股份有限公司 | 可用作蛋白激酶抑制剂的氨基嘧啶类化合物 |
JP5393489B2 (ja) * | 2007-03-09 | 2014-01-22 | バーテックス ファーマシューティカルズ インコーポレイテッド | 蛋白キナーゼの阻害剤として有用なアミノピリミジン |
EP2137177B1 (de) | 2007-04-05 | 2014-05-07 | Amgen, Inc | Aurora-kinasemodulatoren und verwendungsverfahren |
MX2009011059A (es) | 2007-04-13 | 2009-11-26 | Vertex Pharma | Aminopirimidinas utiles como inhibidores de cinasas. |
JP5389785B2 (ja) * | 2007-05-02 | 2014-01-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤として有用なチアゾールおよびピラゾール |
AU2008247594A1 (en) * | 2007-05-02 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
JP5572087B2 (ja) * | 2007-05-02 | 2014-08-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害として有用なアミノピリミジン |
GB0709031D0 (en) * | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds |
CN101687852A (zh) * | 2007-05-24 | 2010-03-31 | 沃泰克斯药物股份有限公司 | 可用作激酶抑制剂的噻唑类和吡唑类化合物 |
ES2395581T3 (es) * | 2007-06-20 | 2013-02-13 | Merck Sharp & Dohme Corp. | Inhibidores de quinasas janus |
CN101687821A (zh) * | 2007-06-21 | 2010-03-31 | Irm责任有限公司 | 蛋白激酶抑制剂及其使用方法 |
ES2400104T3 (es) | 2007-07-31 | 2013-04-05 | Vertex Pharmaceuticals Incorporated | Proceso para preparación de 5-fluoro-1H-pirazolo[3,4-b]piridin-3-amina y derivados de la misma |
DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
DE102008015032A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
ES2413806T3 (es) * | 2008-03-20 | 2013-07-17 | Amgen Inc. | Moduladores de la aurora cinasa y método de uso |
WO2010019473A1 (en) | 2008-08-14 | 2010-02-18 | Amgen Inc. | Aurora kinase modulators and methods of use |
WO2010027921A1 (en) * | 2008-09-03 | 2010-03-11 | Vertex Pharmaceuticals Incorporated | Co-crystals and pharmaceutical formulations comprising the same |
GB0820819D0 (en) | 2008-11-13 | 2008-12-24 | Sareum Ltd | Pharmaceutical compounds |
EP3936508B1 (de) | 2008-12-03 | 2023-12-06 | The Scripps Research Institute | Zusammensetzung umfassend stammzellkulturen |
DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
KR20240011244A (ko) | 2009-01-16 | 2024-01-25 | 엑셀리시스, 인코포레이티드 | 암의 치료를 위한 n-(4-{〔6,7-비스(메틸옥시)퀴놀린-4-일〕옥시}페닐)-n'-(4-플루오로페닐)사이클로프로판-1,1-디카르복사미드의 말산염 및 그 결정형 |
EP2396307B1 (de) * | 2009-02-11 | 2014-10-15 | Merck Patent GmbH | Neue amino-azaheterocyclische carboxamide |
UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
EP2470510B1 (de) | 2009-09-30 | 2014-05-14 | TransTech Pharma, LLC | Substituierte imidazol-derivate für die behandlung von alzheimers krankheit. |
WO2011130459A1 (en) | 2010-04-14 | 2011-10-20 | Bristol-Myers Squibb Company | Novel glucokinase activators and methods of using same |
WO2012066578A2 (en) * | 2010-11-18 | 2012-05-24 | Kasina Laila Innova Pharmaceuticals Private Limited | Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof |
US9090633B2 (en) | 2010-11-18 | 2015-07-28 | Kasina Laila Innova Pharmaceuticals Private Limited | Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof |
US8785459B2 (en) * | 2011-12-27 | 2014-07-22 | Development Center For Biotechnology | Quinazoline compounds as kinase inhibitors |
GB201202027D0 (en) | 2012-02-06 | 2012-03-21 | Sareum Ltd | Pharmaceutical compounds |
DK3040336T3 (da) | 2012-03-02 | 2020-06-22 | Sareum Ltd | Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande |
CN103788085B (zh) * | 2012-10-31 | 2016-09-07 | 复旦大学 | 2-(喹唑啉-4-氨基)-5-噻唑甲酰胺类衍生物及其生物药物用途 |
CN104098551B (zh) * | 2013-04-03 | 2019-03-22 | 广东东阳光药业有限公司 | 作为欧若拉激酶抑制剂的取代喹唑啉类衍生物 |
EP3046584B1 (de) | 2013-09-16 | 2017-07-19 | AstraZeneca AB | Therapeutische polymernanopartikel sowie verfahren zur herstellung und verwendung davon |
KR20180086187A (ko) | 2015-10-05 | 2018-07-30 | 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 | 자가포식 유동의 활성체 및 포스포리파제 d 및 타우를 포함하는 단백질 응집물의 클리어런스 및 단백질질환의 치료 |
GB201617871D0 (en) | 2016-10-21 | 2016-12-07 | Sareum Limited | Pharmaceutical compounds |
AR112027A1 (es) * | 2017-06-15 | 2019-09-11 | Biocryst Pharm Inc | Inhibidores de alk 2 quinasa que contienen imidazol |
US20220289692A1 (en) * | 2019-09-06 | 2022-09-15 | Inflazome Limited | Nlrp3 inhibitors |
CN110746398A (zh) * | 2019-10-18 | 2020-02-04 | 刘沛友 | 4-杂环取代喹唑啉类衍生物及其制备方法和用途 |
CN111574473A (zh) * | 2020-06-04 | 2020-08-25 | 宁夏农林科学院农业资源与环境研究所(宁夏土壤与植物营养重点实验室) | 一种氨基噻唑类化合物的合成方法 |
CN113311166B (zh) * | 2021-04-28 | 2022-10-28 | 新疆农垦科学院 | 一种用于绵羊早期妊娠诊断的蛋白生物标志物及其用于绵羊早期妊娠检测的方法 |
CN115557601A (zh) * | 2022-11-08 | 2023-01-03 | 成都理工大学 | 生物质微球及其制备方法与应用、生物反应器、地下井 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3870725A (en) * | 1971-03-30 | 1975-03-11 | Lilly Industries Ltd | Nitrothiazole derivatives |
US5710158A (en) * | 1991-05-10 | 1998-01-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
ATE159009T1 (de) | 1991-05-10 | 1997-10-15 | Rhone Poulenc Rorer Int | Bis mono- und bicyclische aryl- und heteroarylderivate mit inhibierender wirkung auf die egf und/oder pdgf-rezeptor tyrosinkinase |
NZ243082A (en) * | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
IL117620A0 (en) * | 1995-03-27 | 1996-07-23 | Fujisawa Pharmaceutical Co | Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same |
GB9514265D0 (en) * | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
US6716575B2 (en) * | 1995-12-18 | 2004-04-06 | Sugen, Inc. | Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
TW436485B (en) | 1997-08-01 | 2001-05-28 | American Cyanamid Co | Substituted quinazoline derivatives |
GB9800575D0 (en) * | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
GB9800569D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
EP1119567B1 (de) * | 1998-10-08 | 2005-05-04 | AstraZeneca AB | Chinazolin derivate |
GB9922171D0 (en) * | 1999-09-21 | 1999-11-17 | Zeneca Ltd | Chemical compounds |
-
2001
- 2001-06-21 DE DE60133897T patent/DE60133897D1/de not_active Expired - Fee Related
- 2001-06-21 CA CA002412592A patent/CA2412592A1/en not_active Abandoned
- 2001-06-21 EE EEP200200715A patent/EE200200715A/xx unknown
- 2001-06-21 CN CNB018146201A patent/CN1267431C/zh not_active Expired - Fee Related
- 2001-06-21 RU RU2003102389/04A patent/RU2283311C2/ru not_active IP Right Cessation
- 2001-06-21 PL PL01360439A patent/PL360439A1/xx not_active Application Discontinuation
- 2001-06-21 HU HU0301236A patent/HUP0301236A2/hu unknown
- 2001-06-21 WO PCT/SE2001/001450 patent/WO2002000649A1/en active IP Right Grant
- 2001-06-21 EP EP01944061A patent/EP1299381B1/de not_active Expired - Lifetime
- 2001-06-21 AU AU2001266505A patent/AU2001266505A1/en not_active Abandoned
- 2001-06-21 BR BR0111754-8A patent/BR0111754A/pt not_active IP Right Cessation
- 2001-06-21 MX MXPA02011974A patent/MXPA02011974A/es unknown
- 2001-06-21 US US10/311,916 patent/US6919338B2/en not_active Expired - Fee Related
- 2001-06-21 IL IL15324601A patent/IL153246A0/xx unknown
- 2001-06-21 CZ CZ20024120A patent/CZ20024120A3/cs unknown
- 2001-06-21 AT AT01944061T patent/ATE394102T1/de not_active IP Right Cessation
- 2001-06-21 SK SK1810-2002A patent/SK18102002A3/sk unknown
- 2001-06-21 NZ NZ522696A patent/NZ522696A/en unknown
- 2001-06-21 KR KR1020027017913A patent/KR20030014411A/ko not_active Application Discontinuation
- 2001-06-21 ES ES01944061T patent/ES2305081T3/es not_active Expired - Lifetime
- 2001-06-21 JP JP2002505773A patent/JP2004501914A/ja active Pending
- 2001-06-28 AR ARP010103092A patent/AR030432A1/es not_active Application Discontinuation
-
2002
- 2002-11-19 ZA ZA200209412A patent/ZA200209412B/en unknown
- 2002-12-11 BG BG107376A patent/BG107376A/bg unknown
- 2002-12-13 NO NO20026010A patent/NO20026010L/no unknown
- 2002-12-17 IS IS6656A patent/IS6656A/is unknown
-
2003
- 2003-07-31 HK HK03105517A patent/HK1053124A1/xx not_active IP Right Cessation
-
2005
- 2005-03-02 US US11/070,057 patent/US20060046987A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR030432A1 (es) | 2003-08-20 |
BR0111754A (pt) | 2003-04-29 |
MXPA02011974A (es) | 2004-09-06 |
ES2305081T3 (es) | 2008-11-01 |
NO20026010D0 (no) | 2002-12-13 |
ZA200209412B (en) | 2004-02-19 |
EE200200715A (et) | 2004-08-16 |
KR20030014411A (ko) | 2003-02-17 |
EP1299381B1 (de) | 2008-05-07 |
BG107376A (bg) | 2003-09-30 |
CN1267431C (zh) | 2006-08-02 |
CN1496364A (zh) | 2004-05-12 |
HUP0301236A2 (hu) | 2003-10-28 |
NO20026010L (no) | 2002-12-13 |
CZ20024120A3 (cs) | 2003-03-12 |
JP2004501914A (ja) | 2004-01-22 |
IL153246A0 (en) | 2003-07-06 |
PL360439A1 (en) | 2004-09-06 |
HK1053124A1 (en) | 2003-10-10 |
WO2002000649A1 (en) | 2002-01-03 |
ATE394102T1 (de) | 2008-05-15 |
NZ522696A (en) | 2004-08-27 |
SK18102002A3 (sk) | 2003-07-01 |
US6919338B2 (en) | 2005-07-19 |
EP1299381A1 (de) | 2003-04-09 |
CA2412592A1 (en) | 2002-01-03 |
AU2001266505A1 (en) | 2002-01-08 |
RU2283311C2 (ru) | 2006-09-10 |
US20030187002A1 (en) | 2003-10-02 |
US20060046987A1 (en) | 2006-03-02 |
IS6656A (is) | 2002-12-17 |
WO2002000649A9 (en) | 2007-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60133897D1 (de) | Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren | |
DE60113719D1 (de) | Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten | |
ATE461171T1 (de) | Neue mandelsäurederivate und deren verwendung als thrombininhibitoren | |
DE60332023D1 (de) | Chinolinderivate und deren verwendung als mycobakterielle inhibitoren | |
ATE367381T1 (de) | Neue spirotricyclische derivate und deren verwendung als phosphodiesterase-7-inhibitoren | |
DE60036803D1 (de) | Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel | |
ATE375983T1 (de) | Bakterielle gyrase-hemmer und deren verwendung | |
DE602004021037D1 (de) | Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren | |
ATE419849T1 (de) | Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren | |
ATE302193T1 (de) | Benzoheterozyklen und ihre verwendung als mek inhibitoren | |
DE60023903D1 (de) | Pyrimidin-2,4,6-trionen und deren verwendung als metalloproteinase inhibitoren | |
ATE348805T1 (de) | 2-acyl-indolderivate und deren verwendung als antitumormittel | |
DE60112607D1 (de) | 3-arylindolderivate und deren verwendung als cb2-rezeptoragonisten | |
ATE277910T1 (de) | Urazil verbindungen und deren verwendung | |
DE60123210D1 (de) | Picolinsäure-derivate und ihre verwendung als fungizide | |
DE59908600D1 (de) | Substituierte benzimidazole und ihre verwendung als parp inhibitoren | |
DE60139477D1 (de) | 2-cyanopyrrolidin-derivate und ihre verwendung als arzneimittel | |
DE50105955D1 (de) | Indol-3-yl-derivate und deren verwendung als integrin-inhibitoren | |
ATE418543T1 (de) | Substituierte 1,4-dipiperidin-4-yl- piperazinderivate und deren verwendung als neurokininantagonisten | |
ATE329906T1 (de) | Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren | |
DE60116894D1 (de) | C-nitrosoanilinverbindungen und deren mischungen als polymerisationsinhibitoren | |
ATE500242T1 (de) | Substituierte 1-piperidin-4-yl-pyrrolidin-3-yl- piperazinderivate und deren verwendung als neurokinin antagonisten | |
DE50115716D1 (de) | Tetrakisfluoroalkylborat-Salze und deren Verwendung als Leitsalze | |
ATE551329T1 (de) | Chinazolinonderivate und deren verwendung als cb- agonisten | |
DE60037183D1 (de) | Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |